AC
Aceragen
ACGN·NASDAQRTP NCFounded 201015 employees
Micro CapbiotechPublicRare DiseasePulmonology
Platform: Rare Lung
Market Cap
$0.02B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ACGN)
Loading ACGN stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Liramavacamten | ACG-3349 | Preclinical | 2 | PD-1 | Urothelial Ca | ||
| ACG-4705 | ACG-4705 | NDA/BLA | 1 | BET | Bladder CaEndometrial Ca |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)